Introduction {#sec1}
============

Down syndrome (DS) is one of the commonest genetic conditions worldwide \[[@cit0001]\] characterised by facial dysmorphic features, congenital heart defects, and hypotonia. In addition, it is associated with increased frequency of haematological malignancies, autoimmune disorders, and recurrent infections \[[@cit0002]\]. Most of these infections are recurrent respiratory tract infection (RTI) and otitis media (OM) \[[@cit0003]\], suggesting dysfunction of the humoral immune response. These recurrent infections were found to be one of the most significant health problems in school-aged DS children \[[@cit0004]\].

Although many differences between the immune system of the general population and that of DS children have been reported, the clinical relevance of these differences is unclear. Various anatomical and medical co-morbidities commonly associated with DS increase infection susceptibility and could also influence immune responses \[[@cit0005]\]. Several theories about the pathogenesis of immune deficiency in DS have been postulated including over-expression of chromosome 21 genes (e.g. SOD1 and ITGB2) \[[@cit0006]\], zinc deficiency \[[@cit0007]\], and increased apoptosis with increased telomeres loss \[[@cit0008], [@cit0009]\].

As regards hospital admission, DS children on average spend two to three times more time in hospital than other children, with more frequent mechanical ventilation and higher mortality rate \[[@cit0010], [@cit0011]\]*.*

Recent studies demonstrated T lymphocytopaenia in all age groups concerning CD8^+^ cytotoxic T lymphocytes and CD4^+^ helper cells with the absence of the tremendous expansion that is found normally in early infancy, suggesting defective response to antigenic stimulation. Total T lymphocyte numbers gradually approach the values of the general population with advancing age, but it is doubtful whether these cells have normal function and phenotype \[[@cit0012]\]*.*

Severe B cell lymphocytopaenia had been detected in DS patients, with the absence of the normal great expansion in infancy \[[@cit0012]\]*.* Moreover, a significant decrease of B cells (CD19^+^) had been observed in DS foetuses \[[@cit0013]\]*.* Another study on subpopulations of lymphocytes in DS showed lower values of CD16, CD3, and/or 56^+^ natural killer (NK) cells in all age groups \[[@cit0012]\]*.*

We conducted a prospective case-control study to determine whether there were differences for lymphocyte subgroups between DS children and the healthy population. This was done by analysis of expression markers of B lymphocytes (CD19), NK cell (CD56), and T lymphocytes (CD3, CD4, and CD8). The second target for our study was to unravel the correlation between these markers and the likelihood of recurrent infections and hospital admission.

Material and methods {#sec2}
====================

Setting {#sec2.1}
-------

This study was carried out in the Genetic Unit of the Children's Hospital of Mansoura University, Mansoura, Egypt from April 2015 to February 2017. It is one of the most important genetic units in Egypt.

Sample {#sec2.2}
------

The study enrolled 150 cytogenetically documented DS patients (DS group) and 100 controls (CG group). The sample was analysed according to age as follows: group I (6-23 months), group II (2-6 years), group III (7-12 years), and group IV (13-18 years). The DS group included 88 males and 62 females, while the CG group involved 55 males and 45 females. DS patients were selected randomly from the inpatient Genetic unit and outpatient Genetic clinics of Children's Hospital of Mansoura University. Inclusion criteria were karyotype-proven DS, including both genders and age groups, from 6 months to 18 years old. Patients with proven congenital heart diseases (echocardiography was done for all cases), those less than six months old, and those maintained on immunosuppressive therapy were excluded from the study. The study was accepted by the Medical Research Ethical Committee of the Medical Faculty of Mansoura University (Code No: MS/832). Written, informed consent was obtained from all the participants' parents or guardians who agreed to be enrolled in the research.

Methods {#sec2.3}
-------

### History {#s2c1}

All studied groups were subjected to a thorough history evaluation from medical records and interviews carried out by the physicians, including age, gender, place of residence, maternal age, consanguinity, similar condition, history of recurrent infections (including recurrent tonsillitis, OM, pneumonia, upper respiratory tract infections \[URTI\], sinusitis and gastroenteritis \[GE\]) and history of hospital admission due to infections. Patients were labelled to have recurrent tonsillitis if five or more episodes per year were documented \[[@cit0014]\]. As regards OM, it was considered recurrent if three episodes within six months or four or more episodes during a year \[[@cit0015]\]. Recurrent URTIs were assumed at 12 or more episodes per year. Patients were considered to have recurrent pneumonia if they developed three or more attacks in one year \[[@cit0016]\]. Recurrent sinusitis was defined as the occurrence of more than three episodes in one year or the occurrence of chronic sinusitis \[[@cit0017]\]. Recurrent GE was defined as seven recurrent episodes per a year lasting less than 14 days \[[@cit0018]\].

### Examination {#s2c2}

All patients were subjected to clinical examination focusing on general features of DS, anthropometric measurements, cardiac examination, presence of organomegaly, and lymph node enlargement.

Laboratory assessment {#sec2.4}
---------------------

All patients were subjected to complete blood count, differential leukocyte count, and chromosomal culture and flow cytometric analysis for expression markers of B lymphocytes (CD19), NK cells (CD56), and T lymphocytes (CD3, CD4, and CD8). CD3, CD4, and CD8 were used as CD markers for total T lymphocytes, helper T lymphocytes, and cytotoxic T lymphocytes, respectively. Flow cytometry analysis was carried out on an FACS Aria III flow cytometer (BD Biosciences, San Jose, USA). The whole lysis method of blood was used \[[@cit0019]\], and appropriate combinations of monoclonal antibodies (Becton Dickinson Quanti BRITE products) were used to stain peripheral mononuclear cells. The used monoclonal antibodies were clone A3-B1 for CD19, clone MEM-188 for CD56, clone SK7 for CD3, clone B-Z31 for CD8, and clone SK3 for CD4 \[[@cit0020]\]. Histograms were used to illustrate the results using the FACS Diva software package.

Data analysis {#sec2.5}
-------------

Statistical Package for Social Sciences (SPSS) version 15 was used to analyse data. Qualitative data were presented as percentages and numbers. DS and CG groups were compared using χ^2^ test. Quantitative data was presented as mean ±SD. Student t-test was used in comparison of both groups. Correlations between variables were tested using Pearson's correlation coefficient; *p*-values ≤ 0.05 were considered to be statistically significant.

Results {#sec3}
=======

Descriptive data of sample {#sec3.1}
--------------------------

The mean ages for the studied CG and DS groups were 6.11 and 5.56 years, respectively. Recurrence of DS in the same family was higher in the DS group than in the CG group (8.7% vs. 2%, *p* = 0.03). Also, maternal age was significantly increased in the DS group (mean maternal age was 31.27 years for the DS group and 26.01 years for the CG group, *p* \< 0.001). A non-statistically significant difference between both groups was found as regards age (*p* = 0.309), gender (*p* = 0.566), residence (*p* = 0.256), and consanguinity (*p* = 0.264) ([Table 1](#t0001){ref-type="table"}).

###### 

Descriptive data of the sample

  ---------------------------------------------------------------------------------------------------------------------------------------
  Descriptive data              Control group (*n* = 100)   Down syndrome group (*n* = 150)   Significance
  ----------------------------- --------------------------- --------------------------------- -------------------------------------------
  Age (years) Mean ±SD          6.11 ±4.34                  5.56 ±3.82                        *t* = 1.021\
                                                                                              *p* = 0.309

  Gender\                       *n* (%)\                    *n* (%)\                          *χ*^2^ = 0.329\
   Male\                        55 (55)\                    88 (58.7)\                        *p* = 0.566
   Female                       45 (45)                     62 (41.3)                         

  Residence\                    54 (54)\                    70 (46.7)\                        *χ*^2^ = 1.291\
   Urban\                       46 (46)                     80 (53.3)                         *p* = 0.256
   Rural                                                                                      

  Similar condition in family   2 (2)                       13 (8.7)                          *χ*^2\*^ = 4.728\
                                                                                              *p* = 0.03[^\*^](#tf1-1){ref-type="fn"}

  Consanguineous parents        17 (17)                     18 (12)                           *χ*^2^ = 1.246\
                                                                                              *p* = 0.264

  Maternal age (years)\         26.01 ±4.12                 31.27 ±6.65                       *t* = 7.7150\
  Mean ±SD                                                                                    *p* \< 0.001[^\*^](#tf1-1){ref-type="fn"}
  ---------------------------------------------------------------------------------------------------------------------------------------

t -- independent t-test; χ^2^ -- Chi-square test

p-value significant if ≤ 0.05

χ^2\*^-- corrected Chi-square test (Fisher exact test)

Group differences as regards history of recurrent infections and hospital admission {#sec3.2}
-----------------------------------------------------------------------------------

Significant increases in the frequency of URTIs and sinusitis (*p* = 0.022), OM (*p* \< 0.001), and pneumonia (*p* = 0.001) were found in the DS group. Non-statistically significant differences were shown between the CG and DS groups as regards frequency of tonsillitis (*p* = 0.052) and GE (*p* = 0.694). As regards hospital admission, it was significantly higher in the DS group than in the CG group (*p* = 0.003). As regards the type of recurrent infection in the DS group, it was highest for URTIs and sinusitis (50.7%) followed by tonsillitis (40%), GE (31.3%), OM (23.3%), and lastly pneumonia (16.7%) ([Table 2](#t0002){ref-type="table"}).

###### 

Groups differences as regards history of recurrent infections and hospital admission

  -----------------------------------------------------------------------------------------------------------------------------------------------------
                                  Control group *n* = 100 *n* (%)   Down syndrome group *n* = 150 *n* (%)   Significance
  ------------------------------- --------------------------------- --------------------------------------- -------------------------------------------
  Recurrent tonsillitis           28 (28)                           60 (40)                                 *χ*^2^ = 3.788\
                                                                                                            *p* = 0.052

  Recurrent URTIs and sinusitis   36 (36)                           76 (50.7)                               *χ*^2^ = 5.219\
                                                                                                            *p* = 0.022[^\*^](#tf2-2){ref-type="fn"}

  Recurrent OM                    4 (4)                             35 (23.3)                               *χ*^2\*^ = 17.033\
                                                                                                            *p* \< 0.001[^\*^](#tf2-2){ref-type="fn"}

  Recurrent pneumonia             3 (3)                             25 (16.7)                               *χ*^2\*^ = 11.268\
                                                                                                            *p* = 0.001[^\*^](#tf2-2){ref-type="fn"}

  Recurrent GE                    29 (29)                           47 (31.3)                               *χ*^2^ = 0.154\
                                                                                                            *p* = 0.694

  Hospital admission              5 (5)                             27 (18)                                 *χ*^2^ = 9.085\
                                                                                                            *p* = 0.003[^\*^](#tf2-2){ref-type="fn"}
  -----------------------------------------------------------------------------------------------------------------------------------------------------

URTIs -- upper respiratory tract infections; OM -- otitis media; GE -- gastroenteritis; χ^2^ -- Chi-square test;

p-value significant ≤ 0.05

χ^2\*^ -- corrected Chi-square test (Fisher exact test)

Groups differences as regards complete blood count and differential leucocyte count {#sec3.3}
-----------------------------------------------------------------------------------

Statistically significant decreases in WBC count (*p* \< 0.001), neutrophil count (*p* \< 0.001), total lymphocyte count (*p* \< 0.001), monocyte count (*p* \< 0.001), and platelet count (*p* = 0.005) were detected in the DS group. No statistically significant difference was shown between the DS group and the CG group regarding haemoglobin (*p* = 0.127) ([Table 3](#t0003){ref-type="table"}).

###### 

Groups differences as regards complete blood count and differential leucocyte count

  -------------------------------------------------------------------------------------------------------------------------------------------
  Complete blood count parameters   Control group (*n* = 100)   Down syndrome group (*n* = 150)   Significance
  --------------------------------- --------------------------- --------------------------------- -------------------------------------------
  Platelet (PLT/mm^3^)\             302250 ±93894.78            269986.67 ±80860.97               *t* = 2.811\
  Mean ±SD                                                                                        *p* = 0.005[^\*^](#tf3-2){ref-type="fn"}

  Haemoglobin (gm/dl)\              10.95 ±1.37                 10.68 ±1.38                       *t* = 1.533\
  Mean ±SD                                                                                        *p* = 0.127

  WBCs (cell/mm^3^)\                9000.53 ±1262.36            5553.2 ±791.71                    *t* = 24.307\
  Mean ±SD                                                                                        *p* \< 0.001[^\*^](#tf3-2){ref-type="fn"}

  Neutrophils (cell/mm^3^)\         4178.2 ±847.05              3099.67 ±621.79                   *t* = 10.922\
  Mean ±SD                                                                                        *p* \< 0.001[^\*^](#tf3-2){ref-type="fn"}

  Lymphocytes (cell/mm^3^)\         4135.6 ±890.27              1834.8 ±347.1                     *t* = 24.627\
  Mean ±SD                                                                                        *p* \< 0.001[^\*^](#tf3-2){ref-type="fn"}

  Monocytes (cell/mm^3^)\           436.8 ±60.13                368.07 ±85.1                      *t* = 7.48\
  Mean ±SD                                                                                        *p* \< 0.001[^\*^](#tf3-2){ref-type="fn"}
  -------------------------------------------------------------------------------------------------------------------------------------------

t -- independent t-test;

p-value significant ≤ 0.05

Groups differences as regards CD markers of B and T lymphocytes and natural killer cells in different age groups {#sec3.4}
----------------------------------------------------------------------------------------------------------------

As regards groups I, II, and III, a statistically significant decrease in all studied CD markers was found in the DS group when compared with the CG group (*p* \< 0.001). While for group IV, statistically significant decreases were found in CD4, CD19, and CD56 (*p* \< 0.001) in the DS group when compared to the CG group. As regards CD3 and CD8, statistically non-significant changes were found (*p* = 0.051 and 0.661 respectively) ([Table 4](#t0004){ref-type="table"}).

###### 

Differences in CDs markers of B and T lymphocytes and natural killer cells between different age groups of Down syndrome and control groups

  CD markers   Group I                                 Group II                                Group III                               Group IV                                                                                      
  ------------ --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- ----------------- ----------------- ----------------- -----------------
  CD3          1450.8 ±324.49                          2545 ±346.38                            1161.47 ±374.25                         2624.86 ±524.3                          1107.37 ±295.85   1949.38 ±398.19   1315.83 ±311.96   1610.91 ±370.42
  *t*-value    11.177                                  14.842                                  9.883                                   2.073                                                                                         
  *p*-value    \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   0.051                                                                                         
  CD4          668 ±139.46                             1447.73 ±191.78                         500.93 ±164.84                          1521.43 ±353.82                         460 ±159          1097.81 ±245.45   574.17 ±168.28    892.73 ±225.79
  *t*-value    16.074                                  16.26                                   12.636                                  3.859                                                                                         
  *p*-value    \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}                                                         
  CD8          782.8 ±226.23                           1120 ±241.31                            657.87 ±236                             1100.57 ±203.82                         650 ±183.76       845.31 ±168.18    750 ±182.16       718.18 ±158.54
  *t*-value    4.942                                   9.554                                   4.604                                   0.445                                                                                         
  *p*-value    \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   0.661                                                                                         
  CD19         416.4 ±126.09                           1348.18 ±345.96                         412.13 ±116.15                          1256 ±134.58                            423.95 ±116.98    783.13 ±79.25     165.83 ±114.13    540 ±53.1
  *t*-value    11.953                                  33.72                                   15.228                                  9.919                                                                                         
  *p*-value    \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}                                                         
  CD56         185.6 ±76.33                            954.55 ±316.95                          230.67 ±91.18                           476 ±43.33                              231.84 ±96.89     475.31 ±95.71     259.17 ±63.6      984.55 ±151.42
  *t*-value    11.1                                    19.128                                  10.531                                  15.22                                                                                         
  *p*-value    \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}   \< 0.001[^\*^](#tf4-2){ref-type="fn"}                                                         

t -- independent t test;

p-value significant ≤ 0.05

Correlations between CD markers and hospital admission and sum of recurrent infections in the Down syndrome group {#sec3.5}
-----------------------------------------------------------------------------------------------------------------

Non-significant negative correlations were found between CD19 and CD56 and recurrent infections (*r* = --0.05, *p* = 0.545; and *r* = --0.07, *p* = 0.396, respectively). Also, insignificant negative correlations were found between CD19 and CD56 and hospital admission (*r* = --0.06, *p* = 0.565; and *r* = --0.08, *p* = 0.41, respectively). Non-significant positive correlations were found between CD3, CD4, and CD8 and recurrent infections (*r* = 0.05, *p* = 0.55; *r* = 0.022, *p* = 0.79; and *r* = 0.062, *p* = 0.458, respectively). Insignificant positive correlations were found between CD3, CD4, and CD8 and hospital admission (*r* = 0.051, *p* = 0.555; *r* = 0.026, *p* = 0.8; and *r* = 0.07, *p* = 0.51, respectively) ([Table 5](#t0005){ref-type="table"}).

###### 

Correlations between CDs markers and recurrent infections and hospital admission in Down syndrome group

           Recurrent infections   Hospital admission              
  -------- ---------------------- -------------------- ---------- ---------
  *CD19*   *--0.05*               *0.545*              *--0.06*   *0.565*
  *CD56*   *--0.07*               *0.396*              *--0.08*   *0.41*
  *CD3*    *0.05*                 *0.55*               *0.051*    *0.555*
  *CD4*    *0.022*                *0.79*               *0.026*    *0.8*
  *CD8*    *0.062*                *0.458*              *0.07*     *0.51*

r -- Spearman correlation coefficient; p significant if ≤ 0.05

Discussion {#sec4}
==========

Down syndrome children are more liable for have recurrent infections, autoimmune disorders, and leukaemia, suggesting immune dysfunction \[[@cit0021]\]. We conducted a prospective case-control study in a cohort of Egyptian DS children, aiming at evaluating the CD profile of these patients regarding B lymphocytes (CD19), NK cells (CD56), and T lymphocytes (CD3, CD4, and CD8). We also tried to unravel the correlations between these markers and the likelihood of recurrent infections and hospital admission due to infections.

Our study revealed that the DS group had a significant increase in recurrent infections in the form of URTIs and sinusitis, OM, and pneumonia, with a significant increase in hospital admission over the CG group. However, both groups showed no statistically significant difference regarding recurrent tonsillitis and GE. Our findings are supported by de Vries \[[@cit0022]\], who documented that immunodeficiency in DS children is commonly presented by recurrent URTIs and chest infections in infancy and early childhood. Our findings also go hand in hand with a study from the Netherlands done on 22 DS children and their healthy siblings, which found a higher frequency of RTIs (*p* = 0.001) with more hospitalisations (*p* = 0.007) among the DS group. An insignificant difference between both DS and healthy siblings was observed in this study regarding frequency of GE (*p* = 1) \[[@cit0023]\].

As regards the pattern of infection in our study, it was higher for URTIs, followed by tonsillitis, GE, OM, and lastly pneumonia. This pattern is similar to a recent study in which the frequency of URTIs was the highest (84%) \[[@cit0021]\]. This finding supports the idea that recurrent URTIs are still a significant health problem among DS children and require more attention. URTIs increase hospital admission and are associated with a lower health-related life quality \[[@cit0003], [@cit0004], [@cit0024]\].

In our study, there was significant decrease in total leucocyte count, neutrophil count, and total lymphocytes and monocytes. This is in agreement with Bloemers *et al.* \[[@cit0025]\], who found in their study of 82 cases (41 control and 41 DS) that there were significantly lower counts of total lymphocytes, total leukocytes, granulocytes, and monocytes in the DS group than in the general population. Also, prior literature reports are in agreement with our study \[[@cit0012], [@cit0026], [@cit0027]\]. From our study, we found that the core of immune dysfunction in DS could be related to alteration of these parameters. However, Zampieri *et al.* \[[@cit0028]\] reported a significant decrease in total lymphocyte count but no significant difference in the count of neutrophils and monocytes when compared with controls.

CD3 count was significantly decreased in the DS group in age groups under 13 years, while there was a non-significant difference in CD3 levels in age groups over 13 years, supporting the theory that with increasing age the difference in the count of total T lymphocytes (CD3) between the DS and general population decreases, and thus apoptosis is not the cause of immune-dysfunction in DS. This finding is supported by Faddan *et al.* \[[@cit0029]\], who assessed apoptosis markers using flow cytometry in peripheral lymphocytes in 30 cases (15 DS and 15 control) and found an insignificant tendency towards apoptosis in DS.

As regards CD4, a statistically significant decrease was described in all age groups. This is in agreement with a study from the Netherlands in which CD4^+^ invariant NK T cells, CD4^+^ T lymphocytes, and CD4^+^CD25^high^ T cells were significantly decreased in DS children compared to their siblings \[[@cit0023]\]. Moreover, a more recent study reported that levels of CD4, CD19, and CD3 were significantly lower in a DS group (85 patients and 64 controls, *p* \< 0.05) \[[@cit0030]\]. On the other hand, Cetiner *et al.* \[[@cit0031]\] found higher values of CD4 in DS patients.

Another important finding in our research was the significant decrease in CD8 in age groups under 13 years old in DS. This finding is in contrast to the hypothesis of a link of recurrent infection in DS with continuing anti-inflammatory state in DS. Cetiner *et al.* \[[@cit0031]\] reported in their study a higher percentage of CD8 in 32 DS children and linked the recurrent infection in their DS group to higher CD8 values.

CD19 count in our study was significantly lower in DS patients in all ages. Our finding is similar to Seckin *et al.* \[[@cit0021]\], who studied B lymphocyte dysfunction in 39 DS patients and 37 healthy children and found a significant decrease in CD19 in DS (1061 ±195 vs. 1594 ±410, *p* = 0.001). A reduced number of B lymphocytes has also been shown in DS in several studies \[[@cit0030], [@cit0032], [@cit0033]\]. These studies were carried out in DS children above the age of six years. In common with the findings of the previous studies, the results of our study strongly suggest that DS children have an intrinsic defect of B cell differentiation, causing a significant decrease in the numbers of effector B cells.

Furthermore, a significant decrease in CD56 count was found in the DS group (*p* \< 0.001) in all studied age groups. Our finding is in agreement with several authors who described a significant decrease of cells with high and intermediate NK activity phenotype (CD16^+^ cells and CD56^+^), while cells having low NK activity phenotype (CD31^+^ and CD30^+^) were significantly increased in DS \[[@cit0034]\]. On the other hand, an increased percentage of CD56 in DS children was documented in many reports \[[@cit0026], [@cit0031], [@cit0035]\].

In the DS group, correlations between B lymphocyte subsets and recurrent infections and hospital admission due to infections were insignificant negative correlations. This goes hand in hand with the study by Verstegen *et al.* \[[@cit0033]\], who assessed lymphocyte subpopulations in relation to recurrent RTIs and autoimmune diseases in 95 DS children and 33 control children and did not find a relation between B lymphocyte subpopulations (CD19) and the incidence of allergy or infections in DS. A more recent study found insignificant correlation between CD19 complex expression and infection frequency \[[@cit0021]\].

In our study, there were insignificant positive correlations between expression markers of T lymphocytes and recurrent infections and hospital admission due to infection. This is in agreement with Kusters *et al.* \[[@cit0006]\] who found no association of low count of T cells and the occurrence of recurrent infections.

There were insignificant negative correlations between NK cells and recurrent infections and hospital admission. This is supported by Ribeiro *et al.* \[[@cit0016]\], who evaluated risk factors associated with recurrent infections in DS and found limited value of NK cell dysfunction as a risk factor.

From our study and other previous literature data, we support that recurrent infections and hospital admission in DS might be associated with other factors than immune dysfunction, including co-morbidities such as abnormal anatomy of airways and ears, macroglossia, inability to handle secretions, and reactive airway disease.

Conclusions {#sec5}
===========

In conclusion, the immune status of DS is completely different from that of healthy children. Reduced numbers of lymphocyte subgroups that carry CD3, CD4, CD8, CD19, and CD56 were evident in DS. Recurrent infections and hospital admission are still striking features for DS but are not significantly correlated with lymphocyte subgroups. Our study added data concerning expression markers of immune cells in DS that could be valuable to literature. Several extended studies using more expression markers are needed to improve our knowledge about the immune profile of DS and to understand the exact factors related to immune dysfunction in DS.
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